FRE Stock Overview
A health care company, provides products and services for chronically ill patients.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
First comes the pain, then the money.
Fresenius SE & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €31.95 |
52 Week High | €33.57 |
52 Week Low | €23.93 |
Beta | 1.06 |
11 Month Change | 6.64% |
3 Month Change | 16.10% |
1 Year Change | 9.34% |
33 Year Change | -31.56% |
5 Year Change | -27.45% |
Change since IPO | 2,729.96% |
Recent News & Updates
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)
Aug 19We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt
Jul 15Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively
Jun 12At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
May 28Recent updates
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)
Aug 19We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt
Jul 15Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively
Jun 12At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
May 28With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For
May 02Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Mar 29Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company
Mar 13Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching
Feb 06A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)
Jan 19Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story
Jan 03Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Nov 28Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%
Nov 10Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return
Oct 27Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Sep 03Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
Jul 25We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt
Jun 19At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Jun 01Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal
Apr 18Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear
Mar 13These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Mar 10Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?
Feb 23Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Feb 08The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Jan 03These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Nov 28Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?
Oct 23The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Oct 01Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?
Aug 07Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Jul 20Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital
Jul 02Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92
Apr 28At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Apr 17Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year
Apr 02Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Mar 27Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's
Feb 24Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?
Jan 13Here's Why Fresenius SE KGaA (ETR:FRE) Has A Meaningful Debt Burden
Dec 29Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Dec 14At €41.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Oct 15Shareholder Returns
FRE | DE Healthcare | DE Market | |
---|---|---|---|
7D | 3.4% | 2.8% | 2.8% |
1Y | 9.3% | -2.3% | 4.1% |
Return vs Industry: FRE exceeded the German Healthcare industry which returned -2.3% over the past year.
Return vs Market: FRE exceeded the German Market which returned 4.1% over the past year.
Price Volatility
FRE volatility | |
---|---|
FRE Average Weekly Movement | 3.2% |
Healthcare Industry Average Movement | 3.9% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: FRE has not had significant price volatility in the past 3 months.
Volatility Over Time: FRE's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1912 | 175,771 | Michael Sen | www.fresenius.com |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Fresenius SE & Co. KGaA Fundamentals Summary
FRE fundamental statistics | |
---|---|
Market cap | €18.00b |
Earnings (TTM) | €721.00m |
Revenue (TTM) | €22.63b |
25.0x
P/E Ratio0.8x
P/S RatioIs FRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FRE income statement (TTM) | |
---|---|
Revenue | €22.63b |
Cost of Revenue | €17.41b |
Gross Profit | €5.23b |
Other Expenses | €4.51b |
Earnings | €721.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 06, 2024
Earnings per share (EPS) | 1.28 |
Gross Margin | 23.09% |
Net Profit Margin | 3.19% |
Debt/Equity Ratio | 61.2% |
How did FRE perform over the long term?
See historical performance and comparison